Galaxystar Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.00 Cr
as on 16-11-2024
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.00 Cr
as on 16-11-2024
- Revenue 18.02%
(FY 2023)
- Profit 20.34%
(FY 2023)
- Ebitda 12.19%
(FY 2023)
- Net Worth 726.08%
(FY 2023)
- Total Assets 42.16%
(FY 2023)
About Galaxystar Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹21.00 Cr.
Amit Bishnoi, Gaurav Kumar, and Vikramaditya Ambre serve as directors at the Company.
- CIN/LLPIN
U51909MH2018PTC314815
- Company No.
314815
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2018
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Galaxystar Pharma Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Bishnoi  | Director | 22-Mar-2024 | Current |
| Gaurav Kumar | Director | 30-Sep-2022 | Current |
| Vikramaditya Ambre | Whole-Time Director | 26-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Galaxystar Pharma Distributors.
Galaxystar Pharma Distributors Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.02% increase. The company also saw a substantial improvement in profitability, with a 20.34% increase in profit. The company's net worth Soared by an impressive increase of 726.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Galaxystar Pharma Distributors?
In 2023, Galaxystar Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sundarlal Pharma Distributors Private LimitedActive 6 years 2 monthsAmit Bishnoi, Gaurav Kumar and 1 more are mutual person
- Svs Lifesciences Private LimitedActive 2 years 7 months
Amit Bishnoi and Gaurav Kumar are mutual person
- Saurashtra Medisolutions Private LimitedActive 2 years 10 months
Amit Bishnoi and Gaurav Kumar are mutual person
- Barros Enterprises Private LimitedActive 5 years 3 months
Amit Bishnoi and Gaurav Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Sep 2020 | ₹21.00 Cr | Open |
How Many Employees Work at Galaxystar Pharma Distributors?
Galaxystar Pharma Distributors has a workforce of 63 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galaxystar Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galaxystar Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
